OSAIC HOLDINGS, INC. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$2,057
-82.5%
717
-71.1%
0.00%
Q2 2023$11,764
+71.9%
2,484
-37.9%
0.00%
Q1 2023$6,844
+36.9%
4,002
+43.9%
0.00%
Q4 2022$5,000
+66.7%
2,782
+23.1%
0.00%
Q3 2022$3,000
-40.0%
2,2600.0%0.00%
Q2 2022$5,000
-99.3%
2,260
-30.7%
0.00%
-100.0%
Q1 2022$668,000
+3611.1%
3,260
-3.7%
0.00%
Q4 2021$18,000
-30.8%
3,387
+10.0%
0.00%
Q3 2021$26,000
-36.6%
3,080
-6.1%
0.00%
Q2 2021$41,000
+173.3%
3,280
+420.6%
0.00%
Q1 2021$15,0006300.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders